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PREPARATION, CHARACTERIZATION AND IN VITRO EVALUATION 
OF MULTIFUNCTIONAL MAGNETIC NANOPARTICLES FOR 
TARGETED CANCER THERAPIES 
SUMMARY 
According to World Health Organization’s statistics, it is expected that annual cancer 
cases will rise from 14 million in 2012 to 22 within the next 2 decades. Most 
common clinically used cancer treatments are surgery, chemotherapy, radiation 
therapy etc. However, these treatment options can be invasive and have many side 
effects. The major disadvantage of most chemotherapeutic approaches for cancer 
treatment is that they are non-specific for tumor tissue, hence toxicity to healthy cells 
and manifestation of side effects. To overcome these disadvantages, a new approach 
of using multifunctional magnetic nanoparticles (MNP) can eliminate the 
disadvanteges of traditional treatments. 
Popularly researched MNPs are iron oxides such as magnetite, maghemite, hematite 
and geothite for designing a multifunctional magnetic nanoparticle that can deliver 
drug to the target site. Recently, iron oxide nanoparticles (IONPs) have shown great 
potential in therapeutic and diagnostic applications, such as imaging, magnetic 
hyperthermia treatments and drug delivery systems. IONPs, biocompatibility in 
moderate doses, easy of surface modification, known metabolic pathways, variety of 
their sizes and their magnetic properties allow them to be suitable for therapeutic 
applications. These properties and their ability to be manipulated upon application of 
a magnetic field allow them to be utilized as therapeutic and diagnostic tools. Iron 
oxide nanoparticles have been widely used in preclinical experiments for imaging, 
magnetic hyperthermia and drug delivery.  
Besides the advantages mentioned above, IONPs also might cause cytotoxicity and 
can form free radicals in the system. For this reason, these particles must be modified 
to reduce these effects. One of the most sensitive parameters in toxicity is the surface 
coating of the nanoparticles. To induce lower toxicity, nanoparticles can be coated 
with biocompatible coating, which is an easier, cheaper method comparing to 
synthetic polymers. Also loading anti tumor drugs to MNPs surface is challenging 
without the help of an polymer.so using biocompatible biopolymers for the 
functionalization of nanoparticles by modulating physical and chemical properties 
(surface charge, etc.) improving stability, reducing toxicity and protection of drugs 
and nanoparticles may eliminate existing disadvantages. Also evaluating the 
toxicological effects of MNPs both in vitro and in vivo is crucial for the development 
of MNPs. Therefore, this research reports the synthesis, characterization, and in vitro 
evaluations of multifunctional magnetic iron oxide nanoparticles coated with 
biopolymers. This reported nanodrug system could potentially open up new 
possibilities in the design of therapeutic agents using multifunctional nanoparticles. 
xx 
 
When designing and synthesizing multifunctional nanoparticles all advantages and 
disadvantades previously mentioned must be considered. To reach a positive result 
characterization, optimum polymer concentration determination is important. 
Optimum concentration of the biopolymers can be determined by characterization of 
the colloidal properties of the MNP particles. The desired MNP-biopolymer structure 
suitable for targeted drug delivery must have fully covered surfaces by the 
biopolymers and stabile structures. The flocculation properties of MNPs can be 
determied by their rheological measurements and the surface properties can be 
determied by their electrokinetical measurements. The hydrodynamic radius of the 
MNPs can be controlled by the light scattering experiments. Characterization 
provides an opportunity to analyze the results of experiments and to choose the next 
step to achieve expected results. Characterization techniques are required to 
determine magnetic nanoparticle properties such as size, crystal structure, material’s 
thermal stability, absorbtion spectrum and magnetic behavior. Characterization of 
nanostructured materials is important because human eye cannot determine such 
small structures and their properties. The stabile and fully covered surfaces of the 
MNPs were characterized by the conventional methods such as scanning electron 
microscope (SEM) for the determination of the size and morphology, X-ray 
diffraction (XRD) to determine crystal structure, Fourier transform infrared 
spectroscopy (FTIR) to analyze the chemical bonds and functional groups, 
thermogravimetric analysis (TGA) to determine material’s thermal stability and 
vibrating sample magnetometers (VSM) to measure the magnetic properties.After the 
characterization of MNP, the in vitro evaluations will give insight about biological 
compatibility and toxicity of synthesized particles.  
The only possibility of the targeted drug delivery of magnetic particles is to apply 
external magnetic field. However, when an external magnetic field is applied there is 
a drastic change on the flow properties of the magnetic suspensions. The 
magnetorheological effect of the drug delivery MNPs are rarely researched in the 
literature and very important considering the applications. In this study we examined 
MNPs magnetorheological properties. 
The main purposes this project is to have stable and fully covered surfaces of Fe2O3 
particles by coating with HEC and cellulosic polymers and to obtain non-toxic 
biocompatible multifunctional magnetic particles. When particles reach desired 
properties cancer drugs will be adsored on the particles and the effect of these 
particles on the cancer cells will be examined.  
To achieve the goals mentioned above Fe2O3 particles were treated with biopolymers 
in a variable range of polymer concentration. Particles with optimum polymer 
concentrations were characterized and tested for toxicity. The reported nanodrug 
system in this thesis showed that multifunctional nanoparticles synthesized could 
potentially open up new possibilities in the design of therapeutic agents using them. 
Future efforts could be to investigate the in vivo characteristics of these integrated 
nanostructures. 
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 ÇOK FONKSİYONLU MANYETİK NANOPARÇACIKLARIN HEDEF 
KANSER TEDAVİSİNDE KULLANILABİLMESİ İÇİN HAZIRLANMASI, 
KARAKTERİZASYONU VE İN VİTRO ÇALIŞMALARI 
ÖZET 
Nanoteknoloji son zamanlarda ilaç endüstrisinde, teşhis ve tedavilerde, görüntüleme 
tekniklerinde, vücutta kontrollü ilaç salınımı ve ulaştırmada, doku mühendisliğinde, 
vs. kullanılmaya başlanılmıştır. Birçok farklı nanosistemlerden özellikle çok 
fonksiyonlu manyetik nanoparçacıklar (MNP) bu konuda çok ilgi çekmektedir. 
MNPlerin manyetik alan altında yönlendirilebilmesi özelliği diğer nanoparçacık 
sistemlerine göre daha avantajlı parçacıklar olmalarını sağlamaktadır. Yeni nesil 
tedavi yöntemlerinde sağlıklı hücrelere zarar vermeden ilaç ulaştırma, hedef kitleye 
tedavi için özellikle MNP kullanımları ve avantajları araştırılmaktadır.  
Dünya Saglık örgütünün yayımladığı istatistiklere göre önümüzdeki 20 yılda görülen 
kanser vakalarının 22 milyon gibi bir sayıya ulaşması beklenmektedir. Çok yaygın 
olarak görülen ve ölüm oranları yüksek olan bu hastalığın tedavi yöntemleri sadece 
kemoterapi, radyoterapi ve ameliyat ile sınırlıdır. Bu yöntemler yan etkisi çok olan 
ve invazif yöntemlerdir. Kanser tedavisi için en çok kullanılan yöntemlerden biri 
olan kemoterapi yönteminin en büyük dezavantajı spesifik olmaması ve tümör 
dokusu dışında sağlıklı hücrelere de zarar vermesidir. Bu yöntemlere alternatif olarak 
hedeflendirilmiş ilaçlar düşünülebilir. Bu parçacıklar lokalize halde istenilen bölgeye 
ulaştırılabilecegi için geleneksel tedavi yöntemlerinde görülen yan etkileri azaltabilir. 
Hedeflendirilmiş ilaçlar, seçilmiş etki bölgesi veya bölgelerinde en uygun 
etkileşmeyi sağlayabilmektedir. Ayrıca, etken maddenin dozunun azaltılabilmesine 
ve etken maddenin sadece hedef bölgeye dağılımıyla sınırlandırılmasına olanak 
sağlayabilmektedirler. Böylece oluşabilecek herhangi bir yan etki veya yan etkiler 
büyük oranda minimuma indirilebilecektir. 
Günümüzde, hedeflendirilmiş ilaç modeli için çok fonksiyonlu manyetik 
nanoparçacıkların (MNP) kullanılması araştırmacılar tarafından çok ilgi görmektedir. 
Bu parçacıklar gerekli modifikasyonlarla ilaç yüklenmeye uygun ve manyetik alan 
ile istenilen bölgeye ulaştırılabilnen parçacıklar haline getirilebilirler. Bu yöntem ile 
geleneksel kemoterapinin aksine sadece tümörlü hücrelere müdahale edilebilir ve 
ilaçların sağlıklı hücreleri etkisi azaltılabilir.  
 MNP ile tümörlere üç farklı yol ile müdahale edilebilir. Bunlar: 1- hedef hücre 
tedavisi için MNP’lere ilaç yüklemesi, 2- tümörü MNP ile yüksek sıcaklıklara (dış 
manyetik alan etkisi ile) çıkararak yakmak, 3- spesifik biyomolekülleri MNP’lere 
bağlayarak tümörlere müdahale etmektir. Hedef hücrelere anti-tümör ajanları 
ulaştırarak tedavi etmek geleneksel kemoterapi yöntemine karşılık umut verici, 
alternatif bir yöntemdir. MNP olarak genelde demiroksitler, demir, kobalt gibi 
parçacıklar kullanılır.  
MNPler biyouyumlu olduğu düşünülse bile, vücuda alındığında toksik etki ve serbest 
radikal oluşumu gösterebilmektedir. Bu parçacıkların toksik etkisine sebep olan 
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başlıca nedenlerden biri parçacıkların yüzey yükleridir. Ayrıca farklı bir dezavantaj 
ise MNPlerin kolloidal özelliklerinden dolayı stabil hale getirilmedilerse, bir araya 
toplanıp çökme eğilimleri olmasıdır. Bu dezavantaj parçacıkların vücut içine 
alındığında kan dolaşımına giremelerini engellemektedir ve çeşitli yan etkilere sebep 
olabilmektedir. Amaca uygun bir yapıda hedeflendirilmiş ilaç tasarımı yapabilmek 
için tasarım aşamasında yukarıda belirtilen tüm dezavantajlar göz önüne alınmalıdır.  
Çökme davranışını ve toksik etkilerini iyileştirmek biyopolimerler ile mümkündür. 
Bu etkilerin elimine edilmesi için yüzeylerinin biyolojik uyumlu hale getirilmesi 
gerekmektedir. Bu amaçla MNP yüzeyleri biyopolimerler, grafen gibi malzemeler ile 
kaplanabilirler.Bu polimerler biyo uyumlu ve biyo çözünür oldukları için ilaç 
modellerinde kullanımı sentetik polimerlere göre daha avantajlıdır. Biyopolimerler 
ile kaplama diğer tekniklere göre daha ucuz ve kolay erişilebilinir bir yöntemdir 
ayrıca biyopolimerler anti tümör ilaç yüklemeleri ve parçacıkları stabil hale 
getirilmeleri için iyi bir altyapı sağlamaktadır. Toksik etkileri azaltmak için 
kullanılacak her bir MNP’nin tüm yüzeyinin biyopolimer ile kaplanması 
gerekmektedir. 
MNP’lerin kolloidal özellikleri belirlenerek kararlı parçacıklar elde etmek için 
gerekli biyopolimer konsantrasyonları seçilebilir. Burada istenilen MNP yüzeylerinin 
biyopolimerler ile tamamen kaplı ve kararlı yapılar olmasıdır. Reolojik ölçümler ile 
dispersiyonların akış özellikleri ve floküle olup olmadığı, magnetoreolojik 
ölçümlerle manyetik alan altındaki akış özellikleri, elektrokinetik ölçümler ile 
yüzeylerin kaplanıp kaplanmadığını, ışık saçılması deneyleri ile hidrodinamik 
yarıçaplarını, parçacık boyutlarını ve tüm bu yöntemlerin birlikte yorumlanması ile 
sistemin kararlı olup olmadığını belirleyebiliriz. Kararlı, yüzeyleri tamamen kaplı 
demir oksitlerin geleneksel karakterizasyonları ile görüntüleyebilir (Taramalı 
elektron mikroskopu (SEM), X-ışınları difraksiyonu (XRD), fourier transform 
infrared (FTIR) gibi yöntemler ve kolloidal karakterizasyon sonuçları desteklenebilir. 
Bunlar ile birlikte biyodemirlerin manyetik ve termal karakterizasyonları da önemli 
bilgiler taşırlar. Titreşimli numune magnetometresi (VSM), termal testleri (DSC, 
TGA) gibi testlerin yapılması biyopolimer kaplı demir oksitlerin manyetşk ve termal 
davranışlarını belirlemek için önemlidir. Karakterizasyonların ardından 
biyodemirlerin gerçekten canlı hücrelere zarar verip vermediği canlı dışı (in-vitro) 
hücre deneyleri ile kontrol edilebilir ve ilaç yüklemesi yapıldıktan sonra kanser 
hücrelerine etkisi gözlemlenebilir.  
Tez çalışmasındaki amaçlar; MNP olarak kullanacağımız demiroksit (Fe2O3) 
parçacıklarının üzerine literatürde henüz çalışılmamış olan hidroksietil selüloz 
(HEK) polimerini ve nanokristal yapıdaki ağaç fiberlerinden elde edilen selülozik 
polimeri (NK) kullanarak MNP parçacıklarının kolloidal özelliklerini takip ederek 
kararlı ve MNP parçacıklarının yüzeylerini tamamen kaplanmış numuneler elde 
etmek, polimerlere antitümör ajanları adsorbe ettirerek antikanser özellikli ve 
manyetik alan ile yönlendirilebilen nanoparçacıklar elde etmek ve hedeflendirilmiş 
ilaç literatürüne katkıda bulunmak, son olarak çağımızın hastalığı olan kanserin 
tedavisine yönelik çalışmalara katkıda bulunmak, literatürde kullanılmayan HEK ve 
selülozik polimerlerin kullanılması ile literatüre katkıda bulunmaktır.  
Belirtilen amaçlara ulaşmak için yapılması gerekenler; Sistemlerin akış özellikleri, 
zeta potansiyelleri ve parçacık boyutları bilgisi ile polimer konsantrasyonuna bağlı 
değişimlerini ve etkileşimlerini belirlemek, numunelerin yukarıda belirtilen 
geleneksel karakterizasyonları yapmak ve kolloidal karakterizasyon sonuçları ile 
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uyumu araştırmak, biyopolimer kaplı demiroksitlerin sitotoksisitesi canlı dışı (in-
vitro) hücre deneyleri ile araştırmak, toksik etkiyi minimuma indirmek, in vitro 
deneyler ile sağlıklı hücreler ile etkileşimlerini belirleyerek kullandığımız 
biyopolimerlerin bu tip uygulamalar için uygunluğunu kontrol etmek ve son olarak 
biyopolimer kaplı demir oksitlere antitümör ajanlar yüklenerek ve yine in-vitro 
sitotoksisite deneyleriyle kanserli hücreler üzerindeki etkisi araştırmaktır. Bu 
basamakları uygulayarak belirtilen tüm deneyler yapılmıştır ve sonuçları tezde 
açıklanmıştır.  
Deney sonuçlarına göre sentezlediğimiz çok fonksiyonlu manyetik nanoparçacıkların 
kanser tedavisi için kullanılabilecek hedeflendirilmiş ilaç olabilmeye uygun 
parçacıklar olduğu söylenebilir ve ileride yapılacak terepâtik ilaç tasarımlarıyla ilgili 
çalışmalara yardımcı olacak bilgiler sağlayabilecegi söylenebilmektedir. 
Çalışmalarımızın devamında sentezlediğimiz parçacıkların in vivo (canlı içi) 
testlerindeki davranışlarını araştırmak istemekteyiz.  
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1.  INTRODUCTION 
Over the last decade, nanotechnology has been applied in many industrial sectors, 
including medicine. New generation of targeted drug delivery systems for cancer 
therapy with nanoparticles are highly researched recently. The major disadvantage of 
most chemotherapeutic approaches for cancer treatment is that they are non-specific 
for tumor tissue, hence toxicity to healthy cells and manifestation of side effects. To 
overcome these disadvantages, multifunctional magnetic nanoparticles (MNP) can be 
used. The targeted delivery of anti-tumor agents adsorbed on the surface of MNP’s is 
a promising alternative to conventional chemotherapy. MNPs can be located at the 
targeted site with external magnetic fields and release the drugs adsorbed to their 
surfaces. Magnetic nanoparticles, although may contain other elements, are often 
iron oxides. Most commonly used MNPs are, iron oxides such as magnetite, 
maghemite, hematite and geothite. 
Especially iron oxide nanoparticles (IONPs) atract great attention in biomedical 
applications due to their biocompatibility in moderate doses, easy surface 
modification properties, their relatively well known iron metabolic pathways, variety 
of their sizes and shapes and their magnetic properties. These properties and their 
ability to be manipulated upon application of a magnetic field allow them to be 
utilized as therapeutic and diagnostic tools. Iron oxide nanoparticles have been 
widely used in preclinical experiments for imaging, magnetic hyperthermia and drug 
delivery. In order to successfully transform these applications to clinical trials their 
physicochemical, toxic and functionalization properties must be improved. 
Because of the physiological relevance of iron, MNPs were initially considered to be 
non-cytotoxic. However, it has been shown that due to the small sizes of MNPs can 
reach high local concentrations within the cells and might cause cytotoxicity. 
Furthermore, free iron can form free radicals, which can be  harmful to neural tissues 
[1]. For this reason, these particles must be modified to reduce these effects. One of 
the most sensitive parameters in toxicity is the surface coating of the nanoparticles. 
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The negatively charged uncoated MNPs have been shown to exhibit cytotoxicity 
above a certain threshold amount. Uncoated MNPs also have low solubilities and 
they are less stable which results in nanoparticle precipitation in aqueous media. In 
order to reduce the toxicity of MNPs, different coatings have been used. Such as 
polymers or biopolymers. Coated nanoparticles induce lower toxicity due to the 
presence of the biocompatible coating and the lower adsorption sites for proteins, 
ions and other components in the cell medium [2,3]. Nanoparticles coated with 
biocompatible coating could induce lower toxicity. Also loading anti tumor drugs to 
MNPs surface is challenging without the help of a polymer. Biocompatible 
biopolymers have provided a strategy for the functionalization of nanoparticles by 
modulating physical and chemical properties (surface charge, etc.) improving 
stability, and protection of drugs and nanoparticles [4, 5]. 
The main purpose of this thesis is to have stable and fully covered surfaces of iron 
and iron oxide (Fe2O3) nanoparticles by controlling the colloidal properties with 
cellulosic polymers. The interactions of the polymer and iron oxide (Fe2O3) 
nanoparticles can define the flow properties of the system, the zeta potential values, 
and the magnetorheology. In order to reach previously mentioned goals colloidal 
characterizations will be performed. The conventional characterization of the 
samples will also be performed to compare the colloidal characterization results. The 
in vitro evaluations will be performed to see that whether there are any changes on 
the toxicity or not. The anti-tumor drugs will be adsored on the Fe2O3-biopolymer 
structres and the effect of them on cancer cells and their drug loading efficiencies 
will be controlled. In this study, biopolymer coated iron oxide nanoparticles were 
synthesized, by following the steps mentioned above, to obtain a multifunctional core 
shell nanostructure, which can be used for targeted drug delivery systems for cancer 
therapy [6-9].  
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2.  MAGNETIC NANOPARTICLES  
The magnetic properties, electronic properties and reduced sizes of magnetic 
nanoparticles (MNP) provide many advantageous characteristic properties to the 
nanoparticles. Magnetic properties of MNP’s depend on their size, shape, structure, 
crystallinity, synthesis method and chemistry. Most popular MNP’s used for many 
kinds of applications are iron, cobalt and nickel compounds [10-12].  
2.1 Magnetic Properties  
Magnetic dipole moments of an unmagnetized material are randomly orientated. 
When a material is placed in a magnetic field these moments tend to allign 
themselves in relation to magnetic fields direction. By the materials reaction to a 
magnetic field, all substances are categorised into several groups as, diamagnetic, 
paramagnetic, ferromagnetic and superparamagnetic materials. 
Diamagnetic materials create a magnetization opposite to the direction of applied 
magnetic field. Paramagnetic materials that are attracted by an externally applied 
magnetic fields and thet form a magnetization in the direction of applied magnetic 
field. And ferromagnetic materials such as iron form permanent magnets, or are 
attracted to magnets after ungergoing certain mechanisms (like temperature change) 
[13-16]. The basic types of magnetic behaviour examples are explained in Table 2.1. 
Table 2.1: Types of particles magnetic behaviour (Here spin magnetic moment is 
the magnetic moment induced by the spin of elementary particles). 
Type Spin Alignment 
Ferromagnetic All spins align parallel to one another; spontaneous magnetization 
Paramagnetic Spins tend to align parallel to external magnetic field 
Diamagnetic Spins tend to align antiparallel to external magnetic field 
2.1.1 Iron oxides 
Most popular nanoparticles used for magnetic core structures are iron oxides: 
magnetite (Fe3O4) and maghemite (γ-Fe2O3). Both magnetite and maghemite have 
cubic spinel structures. Magnetite (IUPAC name: (II, III) oxide) is a black or grayish 
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material which contains divalent and trivalent Fe ions and has a chemical formula of 
Fe3O4 or FeO·Fe2O3. For magnetite, net magnetization occurs due to Fe2+ ions from 
octahedral sublattice. Magnetite is sensitive to oxidation and can oxidize its Fe
2+ 
ions 
and transform into maghemite. Maghemite is formed by oxidation of magnetite. 
Contains only trivalent Fe ions and its International Union of Pure and Applied 
Chemistry (IUPAC) name is iron (III) oxide. Chemical formula of Maghemite is γ-
Fe2O3 and has a brownish color. Crystal structure is similar to magnetite, but with 
vacancies in octahedral sites due to oxidation [17, 18]. 
2.1.1.1 Size 
Size of the nanoparticle is important for determining properties of the system; this is 
arguably the most important parameter upon which any IONPs system must be 
designed. Size of the particles affect the dynamics of the magnetic moments in 
magnetic NPs, also particle size is important in the detection and internalization 
IONPs inside mammalians. Magnetic scale lengths such as superparamagnetic radius 
(RSPM) and the single domain radius (RSD) characterize magnetic NP systems. RSPM  
is the maximum particle size up to which a superparamagnetic regime is observed 
and RSD indicates the value below which the formation of magnetic domains is no 
longer energetically favourable [19]. Table 2.2 summarizes these parameters for 
maghemite and magnetite, the most commonly used iron oxides in biomedicine. 
Table 2.2: Characteristic magnetic length scales for iron, maghemite and magnetite 
[20-22]. 
 RSD (nm) RSPM (nm) 
Maghemite 42.5 17.5 
Magnetite 52.7 12.2 
Iron 8.3 8.0 
2.1.1.2 Therapy with iron oxide nanoparticles 
In the last few years, IONPs have also been demonstrated to be useful in clinical 
settings. Mostly researched areas of therapy with MNPs are targeted delivery and 
thermotherapy. Many targeting agents like MNPs, liposomes, micelles dendrimers, 
artificial DNA nanostructures etc, can perform targeted delivery.  Iron oxide NPs 
have been successfully used as a carrier for bioactive molecules in a number of 
conditions both in vitro and in animal models [23, 24].  
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Another promising application of MNPs is thermotherapy of solid tumours. The 
principle of hyperthermia therapy involves the administration of an IONPs fluid 
within the tumour, followed by the application of an alternating magnetic field which 
increases temperature of the targeted region up to 41-46 ºC. The temperature icrease 
causes cellular hyperthermia, which induces apoptosis. Clinical studies for the 
application of thermotherapy showed promising results for many studies.  Using 
IONPs in humans were initiated in 2007 on prostate cancer and glioblastoma 
patients. Afterwards, different clinical assay were carried out for prostate cancer 
metastatic bone cancer recurrent glioblastoma etc. showed tumor necroses with well-
tolerated results and minor or no side effects [25-31]. The illustration of MNP 
therapy mechanism examples can be seen in Figure 2.1. 
 
Figure 2.1 : Therapy with MNPs: (a) by locating MNP +therapeutic molecules at the 
target organ with applied  magnetic field. (b) by heating MNPs 
accumulated in the tumor using alternating magnetic field [32,33]. 
2.2 Multifunctional Core-Shell Nanoparticles  
As mentioned above magnetic nanoparticles have many advantageous properties like 
manipulation by an external magnetic field and their reduced sizes. These properties 
could be beneficial for many applications from various fields such as medicine, 
biomedical, diagnostic (MRI contrast agents), theurapathic (drug delivery), etc. 
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Magnetic carrier nanoparticles can allow transportation to a desired location through 
the control of a magnetic field [33]. Surface coating and functionalization of MNP’s 
may be required to ensure stability, improve biocompatibility and reduce toxicity to 
achieve most efficient results.  
2.2.1 Multifuncional core-shell nanoparticle designs for therapy 
Magnetic nanoparticle carriers consist of three functional parts: a magnetic core, a 
surface coating, and a functionalized outer coating (Figure 2.2). At the center of the 
carrier is the superparamagnetic core which allows for the magnetic manipulation of 
the particle in the presence of an external magnetic field. The composition of the 
magnetic core is dependent on the application. For example, magnetite (Fe3O4) and 
maghemite (γ-Fe2O3) with high oxidative stability are currently the only accepted 
nontoxic magnetic materials for medical applications [34-36]. 
 
Figure 2.2 Magnetic nanoparticle carrier models. 
There are many researchs done about multifuncional core-shell nanoparticle for 
medical aplications such as drug delivery, targeting, imaging, etc. One of the main 
promising therapeutic applications of coated magnetic nanoparticles is for targeted 
chemotherapeutic drug delivery to tumors. Because of their magnetic manipulation 
properties nanoparticles coated with a drug could be injected intravenously, 
transported to a target site (e.g., cancerous tumor) and be retained at the site by 
application of a magnetic field. This form of drug design can increase specificity of 
the drug, localized drug levels significantly, hence doses required for systemic drug 
delivery and potential toxic side effects at nontargeted tissues can be reduced [33-
37]. 
Another interesting technique is using of implanted magnetized stents which can 
capture magnetic particles carrying desired drugs. This technique can allow 
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reapplication without elimination, and localization of the drugs at optimum doses. A 
second important therapeutic application is in the field of hyperthermia, which 
involves heating organs or tissues to between 41 and 46 °C to obtain tumor cell 
necrosis. The application of an external alternating magnetic field to nanosized 
magnetic particles causes heating via hysteresis energy losses [37-41]. 
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3. COLLOIDS 
The term colloid was first used in 1861 by Thomas Graham for the suspentions of 
liquid or solid phases in another liquid. Currently the term colloid is used for 
dispersed insoluble particles suspended throughout another liquid substance [41,42]. 
Particle size is one of the most important parameter that determines the properties of 
colloidal systems. Collodial particles have a size range of 10
-3
 to 1 mm. Recently 
very small nano sized colloidal particles attract great attention for studies [41]. 
Colloids usually have electrical charges. Main contributions to surface charges of 
colloids are due to isomorphic substitutions, chemical reactions and absorbing ions. 
Colloids can that remain dispersed in a liquid for a long time due to their small size 
and electrical charge so it can be said that electrical charges affect colloidal 
behaviour and dispersion properties. Double layer forces occuring between charged 
objects across liquids can affect the systems rheological properties and its zeta 
potential [42, 43]. 
3.1 Classification of Colloidal Systems  
Classification of colloidal systems can be done according to colloidal particle size or 
according to the phase (solid, liquid, or gas) of the dispersed substance and of the 
medium of dispersion. Generally, the latter classification is used for colloidal 
systems and some examples of this classification system are given in Table 3.1. 
Table 3.1: Classification of colloidal systems [41, 42].  
Kolon A Kolon B Kolon C 
Solid Gas Aerosol 
Liquid Gas Aerosol 
Solid Liquid Sol or Colloidal Sol 
Liquid Liquid Emulsion 
Gas Liquid Foam 
Solid Solid Solid Sol 
Liquid Solid Solid Emulsion 
Gas Solid Solid Foam 
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The interaction forces acting between colloidal dispersions play an important part in 
determining the properties of the dispersion. These forces occur when double layer 
systems or particles interact in the dispersion. 
Brownian motion is an irregular motion exhibited by particles of matter when 
suspended in a fluid. Brownian motion, being independent of all external factors, is 
dependent to the thermal motion of the particles in the dispersion. This movement 
behaviour is observed for all types of colloidal suspensions but force types can differ 
to be attractive or repulsive dependening on the structure of the system The 
interaction distances between colloidal objects can affect the forces acting. Main 
reason for repulsive forces is van der Waals forces [41- 45]. 
The Derjaguin–Landau–Verwey–Overbeek (DLVO) theory is built on the 
assumption that the forces between surfaces in a dispersion can be regarded as the 
sum of the contributions of the forces below.  
o Brownian motion and diffusion  
o Electrical double layer forces 
o van der Waals forces 
o Born forces 
3.2 Colloidal Stabilization 
Small particles in the dispersion can move freely in colloidal systems. Brownian 
motion of these small colloidal particles leads to an increased chance of collisions in 
the dispersion. For some systems particles do not separate after the collision (exp.salt 
or polymer added systems) and collisions continue to happen more particles are stuck 
to eachother causing decreased mobility to particles in the dispersion. These events 
can lead to aggregation or phase seperation. Because dispersed particles tend to 
reduce the large interfacial area by aggregation or phase seperation to a continuous 
phase. Gathering of particles in a dispersion is called flocculation when polymer is 
present. Stabilization is required to  prevent flocculation of particles for colloidal 
dispersions. Two mechanisms are known for stabilizing the colloidal state are, 
electric stabilization and steric stabilization (Figure 3.1 and Figure 3.2) [46, 47]. 
Electric stabilization occurs  when the electric charges of the particles are same. 
repulsive forces between the particles  stabilizes the system. Steric stabilization 
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overcomes flocculation by adsorbtion of nonionic surfactants or polymers onto 
particle surface. The second method is the most effective method for overcoming 
flocculation and stabilization. A combination of the two mechanisms is also possible 
for some colloidal systems where aggregation mechanism is inhibited by both 
electrostatic and steric stabilization. This kind of stabilization is called electrosteric 
stabilization and it is usually associated with the adsorption of polyelectrolytes onto 
the particle surface [47, 48]. 
 
Figure 3.1: Electric stabilization of colloidal dispersions. 
 
Figure 3.2:  Steric stabilization of colloidal dispersions. 
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4. RHEOLOGY AND ELECTROKINETIC PROPERTIES 
4.1 Rheology  
The interactions between particles in a disperse system determine the flow 
characteristics (rheology) of these systems. The term ‘Rheology’ was first used by 
Professor Bingham as a definition of the study of deformation and flow of the matter. 
All fluid flow properties are called ‘rheological properties’. Establishing the 
relationship between applied forces and geometrical effects induced by these forces 
at a point in a fluid is one of the purposes of rheology. Some of the subjects of 
rheology are elasticity, plasticity and viscosity [48, 49]. 
4.1.1 Flow models 
Flow behaviour of fluids is determined according to movement of fluid boundary 
layers. According to Newton’s model when a force F is applied to first layer of two 
boundary layers with a surface area of A (apart with a distance of dy), while the 
second layer is stationary, the velocity  of the first layer  will increase  by an amount 
of dv (Figure 4.1). Here dv/dy is determined as shear rate or shear gradient and its 
unit is s
-1
. F/A is determined as shear stress and its unit is Pascal (Pa) [48-53].  
 
Figure 4.1: Relation between applied force (to unit area) to velocity. 
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When the shear stress between the layers of a fluid is directly proportional to the 
shear rate, the fluid is detemined as a Newtonian fluid. The viscosity is independent 
of shear rate for Newtonian fluids (Figure 4.2). To determine the flow behaviour of a 
Newtonian fluid, viscosity measurements will be enough. The mathematical 
represantation is given below for Newtonian Fluids.  
 Shear stress: τ=F/A,                                              (4.1) 
 Shear rate: γ=dv/dy                                               (4.2) 
F/A = η. dv/dy                                                   (4.3) 
τ = η.γ                                                         (4.4) 
All fluid flow behaviours can be determined by plotting their Shear rate- Shear stress 
graph. 
 
Figure 4.2: Flow Behaviour: (a) Shear stress- Shear rate. (b) viscosity - Shear   rate 
graphs for Newtonian Fluids 
Any fluid that does not obey Newton’s law of viscosity is a non- Newtonian fluid.  
For non- Newtonian fluids, linearity is distorted as particles interact with each other 
and loose energy.  Constant that determines viscosity alters as shear rate or shear 
stess changes. Because of these characteristics of flow behaviours two kinds of 
viscosity is determined to explain flow of non-Newtonian fluids and these are; plastic 
and apparent viscosities. Apperent viscosity is a measure of the resistance of a fluid, 
which is being deformed by either shear stress or applied forces. Plastic viscosity is 
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the slope of the shear stress/shear rate line above the yield point where flow is linear 
between certain shear rate values [48-53].  
Fluid flow behaviours can be determined by plotting their Shear rate- Shear stress 
graphs. Non-Newtonian fluids are grouped as plastic, Bingham plastic, shear 
thinning (pseudoplastic), shear thickenning (dilatant) fluids. Many constitutive 
models are available in the literature that describes the rheology of purely viscous 
fluids [48-53]. Basic Non-Newtonian fluid flow behaviours can be seen in Figure 4.3 
and Figure 4.4. 
   
Figure 4.3: Shear stress- Shear rate graphs for Non-Newtonian Fluids. 
          
Figure 4.4: Viscosity - Shear rate graphs for Non-Newtonian Fluids. 
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4.2 Elektrokinetic Properties 
4.2.1 Zeta potential 
Particle interactions and stability of dispersion can be affeted by electrokinetical 
effects. Zeta potential () is the measurement of these electrokinetical effects. The 
electrical double layer consists of two layers of ions from solution, which neutralize 
the surface charge, as shown in Figure 4.5. Colloidal particles like iron oxide 
nanoparticles are charged on the surface when dispersed in a solvent. Charged 
surfaces of the particles atract opposite charge ions to their surfaces.  The electrical 
double layer consists of two layers of ions from solution, which neutralize the 
surface charge, as shown in Figure 4.5. The surface on the particle is immobile and it 
is called the Stern layer. The diffuse layer is much thicker, and is a layer that is 
enriched with ions with opposite charge as the surface. In addition, the near boundary 
between the Stern layer and the diffuse layer is the shear plane. Zeta potential is a 
measure of the potential at the shear plane. When voltage is applied to the particles, 
Stern layer and parts of its diffuse layer move to the opposite charge electrodes. The 
parts left behind of the double layers determine the zeta potential [52-60]. 
 
Figure 4.5: Simplified model of the electrical double layer. The Zeta potential is the 
electrical potential measured at the shear plane [61]. 
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Zeta potential calculations done according to Smoluchowski formula;  
UE= ε ζ / η                                                  (4.5) 
Here UE is; applied electric potential, ε: dielectrik constant, ζ: zeta potential and η: 
viscosity of dispersion [59]. 
4.3 Magnetorheology  
Magnetorheological suspensions show a transition from a liquid behavior to a solid 
when magnetic field is applied. Because of the applied magnetic field magnetizes 
particles that have attractive dipolar forces between them aggregates. Hence the 
phase transition from liquid to solid phase. The basic phenomenon in 
magnetorheology is the ability to control the structure of a biphasic fluid. The two 
phases are composed of solid particles and their carrier fluids. The application of a 
magnetic field induces aggregation of the magnetic particles, hence an increase of the 
viscosity. All these materials have common features regarding the relation between 
the shape and size of the domains of the dispersed phase and their rheology. Even the 
interactions between the dispersed particles can be very different depending on their 
size (polymer, nanoparticle, etc.), conductivity, permittivity, magnetic permeability, 
properties of the interface and so on. Briefly, magnetorheometers are used for 
studying the changes in flow properties that occur in  fluids which are exposed to 
controlled magnetic fields [62-64].  
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5.  BIOPOLYMERS  
Biopolymers are promising candidates for applications in the medical field because 
of their versatility, biocompatibility, bio absorbability and non-toxicity. Latest 
popular polymers in medical fields include new capability polymers like alginate, 
chitin/chitosan, cellulose, hydro gels, hydrocolloids, superabsorbent polymers and 
such others. Biopolymers are usually biodegradable and non-toxic polymers 
produced from natural sources.  Biopolymers are a safer and better alternative to 
traditional plastics, which are petroleum-based. These polymers can be produced 
chemically from biological starting materials like sugars, starch, natural fats or oils, 
etc., or from biological systems systems like microorganisms, plants and animals. 
Four main types of biopolymers are based on starch, sugar, cellulose and synthetic 
materials [64-70].  
5.1 Cellulose  
Cellulose is a biopolymer that has monomeric units of sugars, amino acids and 
nucleotides. Cellulose is primarily defined as the non-branched macromolecule 
containing chain of variable lengths (Figure 5.1). The length of these chains are 
determined by the source of cellulose different .Generally most of natural cellulosic 
fibers contain 60–70% cellulose that is primarily composed of C, H, and O2, having a 
general formula of C6H10O5. But most wood fiber sourced biopolymers has a 
cellulose composition of 40-47% [ 62-65]. 
 
Figure 5.1: Chemical structure of cellulose [69]. 
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5.2 Medical Applications of Biopolymers 
Many of biopolymer applications can be found in the medical fields such as drug 
delivery systems, wound closure, healing products, and surgical implant devices , 
etc. biopolymers have provided a strategy for the functionalization by modulating 
physical and chemical properties (surface charge, etc.) improving the encapsulation, 
stability, and protection of drugs and nanoparticles. The recent development of 
nanotechnology and the various processes of functionalization of biopolymers have 
increased and improved its functionality as drug carrier [66, 67]. 
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6.  EVALUATIONS OF TOXICITY (IN VITRO) 
Non- functionalized iron oxide nanoparticles approved for clinical use display a 
variety of sizes that affect their distribution within the body. Once in the body, the 
iron of the MNPs core is stored in the red blood cells and, like the endogenous iron, 
the coating of the MNP’s decreases storage rate and it is eliminated via  kidneys. 
However, the MNPs interact with different biological systems in the body and may 
have adverse effects. Evaluating the toxicological effects of MNPs both in vitro and 
in vivo is crucial for the development of MNPs-derived applications in medicine. 
in vitro experiments are methods that performed in a laboratory vessel or other 
controlled experimental environments rather than within a living organism or natural 
setting. This method provides controlling of the environment and assesment at e 
cellular level. On the other hand, in vivo experiments occur within a living organism 
or natural setting, which gives information of sistematic interactions. The biological 
response of an organism to exposure of toxicants starts with toxicant induced 
changes at the cellular and biochemical levels, leading to changes in the structure and 
function of the cells, tissues, physiology and behavior of the organism. Having 
insight about toxicant effects at cellular level is important for designing desired drug 
models and to screen designed drugs adverse effects [71]. Mammalian cell 
interactions would give a good insight to whether MNPs functionalized with 
biopolymers have drug potential or not.  
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7. EXPERIMENTAL SECTION 
Iron oxide samples were dispersed in distilled water with ultrasonic bath at different 
solid loadings. Concentration unit of every prepared sample is weight/volume 
percent (w/v). The Fe2O3 dispersions were mixed with different concentrations of 
HEC or NC between the range of 10
-5
 to 1 g/L. The polymers were dissolved in 
distilled water (dH2O). Then, the dispersions were shaken and ultrasonicated for 5 
min. Later Doxorubicin was loaded to biopolymer-MNP structures with the method 
described in section 7.7.4 and cancer cell toxicity of DOX loaded particles were 
evaluated.   
7.1 Characterization of MNPs 
Characterization provides an opportunity to analyze the results of experiments and to 
choose the next step to achieve expected results. Characterization techniques are 
required to determine magnetic nanoparticle properties such as size, crystal structure, 
material’s thermal stability, absorbtion spectrum and magnetic behavior. 
Characterization of nanostructured materials is important because human eye cannot 
determine such small structures and their properties.  
A scanning electron microscope (SEM) is used to determine the size, morphology, 
and qualitative chemical composition of the iron oxide nanoparticles with or without 
biopolymers. SEM scans an electron beam across the entire sample and the signal 
created from electron-sample interaction creates the image [72]. 
X-ray diffraction (XRD) gives information about crystal structure of magnetic 
nanoparticles. Measurements are performed with samples prepared on glass slides at 
room temperature. The elastically scattered or Bragg diffracted x-rays are measured 
in the detector. The sample and the detector are rotated at θ and 2θ respectively to 
obtain diffraction data of the entire sample [73, 74].  
Fourier transform infrared spectroscopy (FTIR) measurements are performed to 
analyze the chemical bonds and functional groups of samples. In FTIR, the incident 
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infrared (IR) beam is first resolved into its individual frequency components via an 
interferometer. The infrared (IR) beam resolved into its individual frequency 
components induces vibrational excitations in sample atoms of the sample. The 
detector measures the IR signal after interaction with the sample. A Fourier 
transform of this signal gives the final IR spectrum in terms of transmission or 
absorption. The spectrum shows the characteristic vibrational frequencies of the 
sample. These results provide information about sample chemical composition and 
the surface functional groups [75]. 
Thermogravimetric analysis (TGA) is an analytical technique used for determination 
of material’s thermal stability and monitoring the weight change that occurs when 
specimen is heated. Measurements are usually carried out in air or in an inert 
atmosphere and the weight change is recorded as temperature increases. In addition 
to weight changes, some instruments (differential thermal analysis or DTA) also 
record the temperature difference between the specimen and one or more reference 
pans. TGA gives quantitative measurements of mass changes related to dissociation 
of bonds, oxidation, surfactant layer, or decomposition of the sample. These 
measurements can also be used for determination of the volatile content in the 
sample [76].  
Vibrating Sample Magnetometers (VSM) are used to measure the magnetic 
properties of materials as a function of magnetic field, temperature, and time. If a 
material is placed within a uniform magnetic field, generated by an electromagnet or 
a superconducting magnet, induction of magnetic moment is observed. In a VSM, 
particles made to undergo sinusoidal motion generates magnetic flux changes which 
is sensed by sensing coils and these sensed signals provide results of magnetic 
moment of the sample  [77].  
7.2 Materials and Methods 
In this study, the main goal is to preparare biopolymer coated superparamagnetic iron 
oxide nanoparticles that can allow drug delivery to tumor tissue by magnetic 
manipulations. Polymer coated superparamagnetic iron oxide nanoparticles were 
synthesized to obtain a biocompatible anticancer nanodrug model. Iron oxide (Fe2O3) 
nanoparticles were purchased from Sigma–Aldrich Co (544884) and used without 
further purifications. Biopolymer used for experiments were 2-Hydroxyethyl 
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cellulose (HEC) and Nanocrystalline Cellulose (NC). HEC (Figure 7.1) was 
purchased from Sigma–Aldrich Co and NC was produced from wood fibers by Ayse 
Alemdar [78]. 
 
Figure 7.1 :Chemical structure representation of HEC [78]. 
7.3 Properties of Iron Oxide Particles  
7.3.1 Rheological and electrokinetical properties  
Iron oxide samples were dispersed in distilled water with ultrasonic bath at different 
solid loadings. Rheological properties such as viscosity, shear rate (γ  ) and shear 
stress (τ) of dispersions were measured using a Brookfield DVIII + type low-shear 
viscometer.  The flow behavior of the clay dispersions was obtained by shear rate 
measurements within 0 to 330 s
-1
 shear rates. Rheological measurements were 
carried out in duplicate. All the measurements were performed at natural dispersion 
pH levels. The rheological properties of different Fe2O3 concentrations were 
examined and flow models of the dispersions were determined from their flow 
curves (Figure 7.2). 
 
Figure 7.2 : Flow behavior: (a) Flow curves. (b) apparent viscosities of Fe2O3 
dispersions with different concentration.  
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All Fe2O3 dispersions showed Non newtonian-type, shear thickening (Dilatant) flow 
behavior.  In this type of flow, the very act of deforming a material can cause a 
rearrangement of its microstructure such that the resistance to flow increases with 
any increase in shear rate. In other words, the viscosity increases with applied shear 
rate and the flow curve can be fitted with the power law; 
k
n
                                                   (7. 1) 
 where n>1 (shear thickening ) flow behavior. As seen on Figure 7.2 increasing 
Fe2O3 concentration does not have a major effect on the flow behavior of Fe2O3 
dispersions. The change of the apparent viscosity of the dispersions is given in 
Figure 7.2 as a function of the shear rate. Rheological properties of Fe2O3 dispersions 
do not show major differences as concentration changes, so 2% Fe2O3 dispersions 
were choosen to be used for further studies because other concentrations (1% and 
3%) are to dilute or concentrated for further experiments. 
The electrophoretic mobility measurements were carried out using a Zetasizer 2000, 
Malvern Instruments. The optic unit contains a 5mW He-Ne (638 nm) laser.  The 
dispersions were prepared as explained above. Before the measurements, all 
dispersions were centrifuged at 4500 rpm for 30 min. Supernatants were then used 
for zeta potential measurements. To make an electrophoretic mobility measurement 
in this instrument, laser beams are crossed at a particular point in the cell. Particles in 
the cell were illuminated by these beams. Electrophoretic mobility was measured, 
injecting a small portion of the dispersion into the cell of the Zetasizer 2000 
instrument at 25
0
C temperature. The electrophoretic mobility was then converted to 
zeta potential using Henry equation.  
Zeta potential value of Fe2O3 particles was masured as -18.6mV. This value indicates 
that the particles tend to flocculate in the dispersion [79]. The interaction of particles 
with each other and the solvent molecules are less than the gravitational force, so the 
particles tend to fall down to the bottom of the tube. 
7.4 Synthesis of Biopolymer Coated Superparamagnetic Iron Oxide 
Nanoparticles  
The Fe2O3 dispersions were mixed with 10
-5
 to 1 g/L at different concentrations of 
HEC or NC. The polymers were dissolved in distilled water (dH2O). Then, the 
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dispersions were shaken and ultrasonicated for 5 min. Rheological and 
electrokinetical properties of the dispersions were determined to find out the proper 
concentrations of each polymer, which covers the whole surfaces of the Fe2O3 
particles’ surface. 
7.5 Interactions with HEC and Fe2O3 
7.5.1 Rheological properties 
Influences of biopolymers upon the Fe2O3 dispersions and their rheological 
properties were examined. Flow curves and apperent viscosities are measured to 
determine the effects of polymers on 2% Fe2O3 dispersions. Effect of HEC on Fe2O3 
dispersions and their rheological properties are shown in Figure 7.3. 
 
Figure 7.3: Shear stess-shear rate graphs of: (a) all HEC concentrations with 2% 
Fe2O3 dispersions. (b) 1g/L HEC+2% Fe2O3 and 2% Fe2O3 dispersions. 
The HEC polymer attached to the some part of the Fe2O3 surfaces and reduced the 
interactions between the ironoxide particles. HEC prevented the rearrangement of the 
particles, as a result the flow regimes changed to the non-interacting regime which is 
called Newtonian flow. The flow curves of the HEC added samples were given in the 
Figure 7.3. 
Because of the different flow regimes, the apparent viscosity values at different 
speeds were used to determine the correlation between the solutions. Figure 7.4 
shows the changes of the apparent viscosity values of dispersions at different speeds 
of the rheometer. Figure 7.4 shows the change of apparent viscosity versus 
increasing HEC concentration. According to the figure, HEC did not change the 
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viscosity of the medium. The last points at apparent viscosity-HEC concentration 
graph indicated the slight increament of the viscosity but indeed it was the viscosity 
increment of the polymer solution. The viscosity values slightly increased with 
increasing speed especially at 250 rpm. Shear thickening behavior of Fe2O3 should be 
the reason of the increasement. 
 
Figure 7.4: Apparent viscosity -HEC concentration graphs for all 2% Fe2O3 
dispersions with different HEC concentrations. Apparent viscosities 
were measured at different speeds (120,200,250) of rheometer.  
7.5.2 Electrokinetical measurements 
The zeta potential measurements were carried out for all 2% Fe2O3 and 2% 
Fe2O3+HEC dispersions with different biopolymer concentrations within the range of 
1x10
-5 
to 1 g/L. Before the measurements all the dispersions were centrifugated at 
4500 rpm for 10 min then their supernatants were used for measurements.In Figure 
7.5, the zeta potential of 2% Fe2O3+HEC dispersions is plotted as a function of 
increasing HEC concentrations. The zeta potential value of the 2% Fe2O3 dispersion 
in the absence of HEC was measured to be -18.6 mV. Zeta potential values of the 
dispersions up to 0.01 g/L HEC concentrations were in a decreasing regime, but 
further increase in HEC concentrations resulted in positive zeta potentials. This 
indicates that positively charged HEC molecules are attach to the negatively charged 
Fe2O3 nanoparticles and covered the whole surface of the particles. The zero point of 
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charge of the 2%Fe2O3+HEC dispersions was measured at ~0.05 g/L polymer 
concentrations. 
 
Figure 7.5: Zeta potential of 2% Fe2O3+HEC dispersions as a function of increasing 
HEC concentration. 
7.5.3 Magnetorheology  
A Magneto Rheolgical Device (MRD 180, Anton Paar Companies, Germany) was 
used for determining the effect of a magnetic field on the rheology of magnetic fluids 
(Fe2O3 dispersions). Different magnetic fields were applied on each sample and the 
effect of magnetic field on sample dispersions flow behaviour, apparent viscosity, 
shear stess and shear rate was examined. In the following test, the test currents were 
0A to 1A with and the intensities of magnetic fields were 0 mT 220 mT. 
In the magnetorheometer, only the lower plate can apply the magnetic field. Hence, 
when we applied the magnetic field, the particles stuck to the lower plate and the 
water in the dispersion released. If we performed the maesurement at this condition, 
the rheological parameters would only belong to the released water. Therefore, the 
water on the rheometer were removed in controled manner before the measurements. 
In this case the rheological parameters of the dispersions changed compared to the 
results of section 7.5.1.  The flow curves of the water-removed dispersions were 
given in Figure 7.6 The magnetic field applied to the same dispersions to compare 
the magnetorheological effects.  
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The viscosity decrease can be seen in Figure 7.6 as polymer concentration changes. 
This indicates that polymers lower the interaction between Fe2O3 particles, which 
changes flow behaviour and decreases viscosity. This property gained by adsorbing 
polymers to Fe2O3 surface. 
 
(a) 
 
(b) 
Figure 7.6: Shear stress plotted as a function of shear rate: for suspensions 
containing different concentrations of HEC under test currents (a) 0A. 
(b) 1A.                                                  
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The viscosity decrease can be seen in Figure 7.6 as polymer concentration changes. 
This indicates that polymers lower the interaction between Fe2O3 particles, which 
changes flow behaviour and decreases viscosity. This property gained by adsorbing 
polymers to Fe2O3 surface. 
7.5.4 Fourier transform infrared spectroscopy (FTIR)  
FTIR spectrum measurements were performed in both transmitance and absorbance 
modes using the Perkin Elmer Spectrum One Spectrophotometer (wavelenth range of 
400-4000 cm
-1
). Each sample of Fe2O3 and Fe2O3 in the presence of different HEC 
concentrations (in the solid state) were mixed with KBr with a sample ratio of %0.1 
weight/weight % (w/w %) and ground very finely with an agate pestle and mortar. 
After each KBr and sample mixture was compressed into a KBr pellet (under ~10 
tons for ~2min) for FTIR spectroscopy measurements. 
 
Figure 7.7: FTIR spectrum of Fe2O3 and 1g/L HEC+ Fe2O3. 
Characteristic Fe-O streching vibration peak was determined at 576 cm-1 for Fe2O3 . 
The results showed that addition of the polymer HEC did not change the spectrum of 
Fe2O3 (as seen on Figure 7.7). 
 The characteristic Fe-O vibration peaks were shifted slightly with addition of the 
polymer HEC as seen in Table 7.1. The reason for this shift was  overlapping of HEC 
and Fe2O3 peaks. No binding peaks were observed as expected. 
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Table 7.1: Fe-O streching vibration peak values for different concentrations of HEC. 
Concentration Fe-O streching vibration peak (cm
-1
) 
2%Fe2O3 576 
10
-5
g/L HEC+ 2%Fe2O3 583 
5x10
-5
g/L HEC+ 2%Fe2O3 574 
10
-4
g/L HEC+ 2%Fe2O3 572 
5x10
-4
g/L HEC+ 2%Fe2O3 579 
10
-3
g/L HEC+ 2%Fe2O3 575 
5x10
-3
g/L HEC+ 2%Fe2O3 577 
10
-2
g/L HEC+ 2%Fe2O3 573 
5x10
-2
g/L HEC+ 2%Fe2O3 578 
10
-1
g/L HEC+ 2%Fe2O3 571 
5x10
-1
g/L HEC+ 2%Fe2O3 572 
1g/L HEC+ 2%Fe2O3 574 
7.5.5 X-Ray diffraction analysis (XRD)  
The crystal structure of Fe2O3 and Fe2O3 in the presence of HEC was measured by 
X-Ray diffraction analysis using Philips PW1040. Each sample was prepared by 
covering glass slides with sample suspentions and leaving them to dry at room 
temperature. Figure 7.8 shows the XRD patterns of the Fe2O3 samples with and 
without HEC. According to these results, no changes were determined as HEC 
concentration changes.  
 
Figure 7.8: X-ray diffraction patterns of Fe2O3, 5x10
-4
g/L HEC+ 2% Fe2O3 and 1g/L 
HEC+ 2% Fe2O3. 
7.5.6 Scanning electron microscope (SEM)  
Scanning electron microscopy (SEM) images of the samples were used for 
characterization of the dispersions with the polymer effect (Figure 7.9). Direct 
evidence of surface modification of the dispersion can be found in SEM examination. 
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SEM images of all Fe2O3 nanoparticles and HEC biopolymer coated Fe2O3 
nanoparticles were obtained for particle size determination and imaging.The 
morphology of the fractured surfaces of the samples was investigated with a FEI 
Quanta Feg 250 scanning electron microscope. SEM measurements were operated at 
15 kV. The specimens were frozen under liquid nitrogen, and then fractured, 
mounted, and coated with gold on Edwards S 150B sputter coater. 
 
Figure 7.9: SEM images of (a) 2% Fe2O3.(b) 5x10
-4 
g/L HEC +2% Fe2O3. (c) 1g/L 
HEC+ 2% Fe2O3 respectively. 
HEC polymer appeared on the ironoxide particles as dotted texture. The increasing 
concentration of HEC polymer increased the number of coated Fe2O3 particles as 
seen on the SEM pictures. 
7.6 Interactions with NC and Fe2O3 
7.6.1 Rheological properties 
Influences of NC biopolymer upon the Fe2O3 dispersions, their rheological properties 
and flow behaviours were examined. Shear stress, shear rate and apperent viscosities 
of all 2% Fe2O3 dispersions with different NC concentrations are measured to 
determine the effects of polymers on Fe2O3 nanoparticles.  
Effect of NC on Fe2O3 dispersions and their rheological properties are shown in the 
figures given below.The flow curves of the NC added samples at all concentrations 
were given at the Figure 7.10 and the differences between the flow curves of Fe2O3 
and 1g/L NC added Fe2O3 samples were given at Figure 7.10. These results indicated 
that NC polymer is attached to some part of the Fe2O3 surfaces and reduced the 
interactions between the iron oxide nanoparticles and changed its flow behavior by 
preventing rearrangement of Fe2O3 nanoparticles. As it can be seen in Figure 7.10  at 
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1g/L NC biopolymer concentrations there is a chance in flow behavior compared to 
2% Fe2O3.  
NC polymer prevented to the rearrangement of the particles (similarly like HEC) so a 
result the flow regimes changed to the non-interacting regime, which is called 
Newtonian flow.  
 
Figure 7.10: Shear stess-shear rate graphs of: (a) all NC concentrations with 2% 
Fe2O3 dispersions. (b) 1g/L NC+2% Fe2O3 and 2% Fe2O3 dispersions. 
Because of the different flow regimes, the apparent viscosity values at different 
speeds were used to determine the correlation between the solutions. Figure 7.11 
shows the changes of the apparent viscosity values of dispersions at different speeds 
of the rheometer. 
 
Figure 7.11: Apparent viscosity-NC concentration graphs for all 2% Fe2O3 
dispersions with different NC concentrations. Apparent viscosities were 
measured at different speeds (120,200,250) of rheometer.  
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7.6.2 Electrokinetical measurements 
The zeta potential measurements were carried out for all 2% Fe2O3 and 2% 
Fe2O3+NC dispersions with different biopolymer concentrations within the range of 
1x10
-5
 to 1 g/L . Before the measurements, all the dispersions were centrifugated at 
4500 rpm for 30 min, then their supernatants were used for measurements. In Figure 
7.12, the zeta potential of 2% Fe2O3+ NC dispersions is plotted as a function of 
increasing NC concentrations. The zeta potential value of the 2% Fe2O3 dispersion in 
the absence of NC was measured to be  -18.6mV. There was only a plateu on the zeta 
potential of the dispersion up to 0.1 g/L NC concentrations but further increase in NC 
concentrations resulted in increasing zeta potentials. While positive zeta potentials 
were reached using HEC, zero point could not be reached for NC biopolymer 
concentrations. This indicates that positively charged NC molecules are still attached 
to the negatively charged Fe2O3 nanoparticles and covered their surfaces but only 
partially. 
 
Figure 7.12: Zeta potential of 2%Fe2O3+ NC dispersions as a function of increasing 
NC concentration. 
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7.6.3 Magnetorheology  
Experiments were performed under same conditions as descibed in section 7.5.3 
Different magnetic fields were applied on each sample of 2% Fe2O3 and NC + 2% 
Fe2O3 disperions and the effect of magnetic field on these samples and their 
rheological properties were examined.  
  
(a) 
 
(b) 
Figure 7.13: Shear stress plotted as a function of shear rate for suspensions 
containing different concentrations of NC under test currents (a) 0A. 
(b)1A.  
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The results were similar with HEC and it can be seen in Figure 7.13 that at 1g/L 
polymer concentration viscosities are much lower (for both polymers) than uncoated 
particles.  
7.6.4 Fourier transform infrared spectroscopy (FTIR)  
FTIR spectrum measurements were performed in both transmitance and absorbance 
modes using Perkin Elmer Spectrum One Spectrophotometer (wavelenth range of 
400-4000 cm
-1
). Each sample (in the solid state) were mixed with KBr with a sample 
ratio of %0.1 w/w and groung very finely with an agate pestle and mortar. After each 
KBr and sample mixture was compressed into a KBr pellet (under ~10 tons for 
~2min) for FTIR spectroscopy measurements. 
 
Figure 7.14: FTIR spectrum of each sample of Fe2O3 and Fe2O3 in the presence of 
different HEC concentrations. 
We have mentioned that characteristic Fe-O streching vibration peak was determined 
at 576 cm
-1
 for Fe2O3 (Figure 7.14). The results of NC added samples were similar to 
HEC added samples. FTIR examination of 1g/L NC added sample showed that 
addition of the polymer did not change the spectrum of Fe2O3. The characteristic Fe-
O vibration peaks were shifted slightly with addition of the polymer (Table 7.2.). The 
reason for this shift was also overlapping of NC and Fe2O3 peaks just like HEC did. 
No binding peaks were observed as expected. 
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Table 7.2: Fe-O streching vibration peak values for different concentrations of NC. 
Concentration Fe-O streching vibration peak (cm
-1
) 
2%Fe2O3 576 
10
-5
g/L NC+ 2%Fe2O3 572 
5x10
-5
g/L NC+ 2%Fe2O3 575 
10
-4
g/L NC+ 2%Fe2O3 571 
5x10
-4
g/L NC+ 2%Fe2O3 579 
10
-3
g/L NC+ 2%Fe2O3 574 
5x10
-3
g/L NC+ 2%Fe2O3 571 
10
-2
g/L NC+ 2%Fe2O3 572 
5x10
-2
g/L NC+ 2%Fe2O3 569 
10
-1
g/L NC+ 2%Fe2O3 569 
5x10
-1
g/L NC +2%Fe2O3 572 
1g/L NC+ 2%Fe2O3 571 
7.7 Drug Testing 
To choose the proper concentrations of the polymers which covers the whole surface 
of the Fe2O3 particle in a stable dispersion, rheological and electrokinetical data was 
used. Addition of HEC did not change the aggregation behavior of the dispersions 
but covered the whole surfaces of the iron oxide particles after the 0.05g/L HEC 
concentration. HEC did not change any structural properties of the iron oxide so the 
attachment of HEC to the Fe2O3 particle surfaces is completely caused by 
electrosteric effects. Positively charged HEC were attracted to the negatively charged 
surface of Fe2O3 and also, HEC changed the charge distribution on the Fe2O3 surface. 
Hence, the HEC particles were attached to the surface by steric effects. The 
electrostatic and steric effect together is called electrosteric effect. 
For the further studies, we decided to use 1g/L HEC concentration because of the 
reasons above. Rheological and the electrokinetical behaviours of HEC were very 
similar only NC was not able to cover Fe2O3 surface as much as HEC. Due to similar 
results, 1g/L NC concentration was choosen to use for further studies.  
7.7.1 Magnetic properties of synthesized Fe2O3 nanoparticles 
As mentioned above 1g/L polymer concentrations of both HEC and NC biopolymers 
were choosen for further studies. The magnetization in a variable magnetic field and 
magnetic properties of Fe2O3 and Fe2O3 in the presence of biopolymer samples (in 
solid state) were determined by a vibrating sample magnetometer (VSM) (Pacıfıc 
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Electric Motor Co.) at room temperature under DC-biased magnetization between 0 
and 8000 Oe. 
 
Figure 7.15: Magnetization graphs for Fe2O3, 1g/L HEC+2% Fe2O3, 1g/L NC+2% 
Fe2O3. 
As seen in Figure 7.15 addition of polymer to the Fe2O3 particles reduced the 
magnetization values slightly but did not change the characteristic response of Fe2O3 
particles to the magnetic field.  
7.7.2 Thermo-gravimetric and differential thermal analysis (TG/DTA) of  
synthesized Fe2O3 nanoparticles 
The thermal analyses of the samples were determined using thermo gravimetric (TG) 
and differential thermal analysis (DTA). TG/DTA was performed in a Perkin Elmer 
Diamond at a heating rate of 20 °C/min under an argon atmosphere and in the 
temperature range of 30 and 300 °C. The results in Figure 7.16 showed that uncoated 
Fe2O3 particles gained significant amount of weight at temperatures in the range of 30 
to 300 °C. This indicates that these particles were oxidized when uncoated. Coated 
and uncoated Fe2O3 particles showed different weigth lost events. HEC and NC 
coated particles were not oxidized because of coatings prevented Fe2O3 particles to 
intreract with the environment, so, they are not oxidized and they lost weight due to 
the polymers weigth lost. 
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Figure 7.16: TG/DTA thermal analysis graphs: (a) TG. (b)DTA for 1g/L NC+2% 
Fe2O3, 1g/L HEC+     2%Fe2O3, and 2%Fe2O3. 
The results in Figure 7.16 showed that uncoated Fe2O3 particles gained significant 
amount of weight at temperatures in the range of 30 to 300 °C. This indicates that 
these particles were oxidized when uncoated. Coated and uncoated Fe2O3 particles 
showed different weigth lost events. HEC and NC coated particles were not oxidized 
because of coatings prevented Fe2O3 particles to intreract with the environment, so, 
they are not oxidized and they lost weight due to the polymers weigth lost. 
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7.7.3 In vitro evaluations 
In order to assess whether synthesized Fe2O3 nanoparticles could have anticancer 
drug potential and targeted drug delivery properties in vitro evaluations were 
performed. To examine the toxicity of synthesized Fe2O3 nanoparticles and DOX 
loaded nanoparticles cytotoxicity assays were performed for all nanoparticle 
samples(in solid state) using MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assays. The quantity of 
formazan product produced by MTS was measured at 490nm with ELISA multiwell 
spectrophotometer (BIO-RAD Benchmark Plus). MTS was purchased from Promega 
(CellTiter 96® AQueous One Solution Cell Proliferation Assay). Cytotoxicity assays 
were applied to Human osteoblast (hFOB) and human breast adenocarcinoma 
(MCF7) cell lines. All cell lines were purchased from ATCC. 
7.7.3.1 Mammalian cell culture 
All cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (HyClone, 
16777-133) supplemented with 10% fetal bovine serum (FBS) (HyClone, 
SH3007003HI), 1% penicillin-streptomycin, 1% L-Glutamine solution. All 
incubations were performed in a humidified atmosphere containing 5% CO2 at 37
°
C 
(BINDER, C150 E2). For experimental procedures all cells were detached by 0.5% 
Trypsin-EDTA solution (Sigma, T3924), washed two times with PBS, and 
resuspended in DMEM. Medium renewals of all cells were performed 2 to 3 times 
per week. 
7.7.3.2 Cytotoxicity assays 
Growth of the cell cultures were optimized before performing cytotoxicity assays. 
To quantitatively measure cell cytotoxicity, proliferation or viability of the 
nanoparticles a colorimetric MTS assay was used as mentioned above. MTS solution 
was stabilized by electron coupling reagent phenazine ethosulfate (PES). The 
quantity of formazan product measured by 490nm absorbance was subtracted from 
background absorbances (680nm) and assays are done multiple times for at least six 
wells per sample. For MTS assays, the quantity of formazan product measured is 
directly proportional to the number of living cells in culture so cell viability can be 
measured.  
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The relative cell viability (%) related to control wells (medium without 
nanoparticles) was calculated by; 
                        (7. 2) 
For cytotoxicity assays hFOB and MCF7 cells were used. Cells were seeded in a 96 
well plate at a density of 10,000 cells per well in 100 l of medium. After Different 
concentrations (400, 250, 200, 100, 50, 25 l/ml) of Fe2O3 nanoparticles (without 
biopolymer treatment) 1g/L NC+ 2% Fe2O3 and 1g/L HEC+ 2% Fe2O3 were 
prepared with DMEM supplemented with 10% FBS and added to wells. The control 
wells were only cultured cells in medium with no particles. Fe2O3 and 1g/L HEC+ 
2% Fe2O3 treated cells in 96 well plates, cultured in DMEM supplemented with 10% 
FBS, were incubated for 24 h at 37 
°
C in a 5% CO2 incubator. After 24h, MTS assays 
were performed by adding MTS (10% of culture medium) directly to culture wells. 
MTS added cultures were incubated for 4 hours then their absorbances were 
measured at 490nm and at 680nm (background) with a 96-well plate reader. Cell 
viability % of all treated cells were determined by using the formula mentioned 
above. 
 
Figure 7.17: Relative cell viability (%) of hFOB treated with 1g/L HEC+2% Fe2O3, 
for 1g/L NC+2% Fe2O3 and 2% Fe2O3 (without biopolymer treatment) 
dilutions (25-400g/ml) related to control wells. 
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As seen in Figure 7.17 HEC and NC coated Fe2O3 nanoparticle dilutions have 
considerably less toxicity to osteoblast cells than uncoated Fe2O3 dilutions. 
Absorbans increase at 25g/ml measured with the MTS assay may be due to 
increased mitochondrial activity associated with cell phagocytosis of nanoparticles. 
Especially at 200g/ml concentrations, maximum difference of cell viability can be 
observed. Experimental values indicate that HEC and NC coated Fe2O3 nanoparticles 
has less cell toxicity and these nanoparticles may have potential to be used as a drug 
targeting and delivering model with less toxicity to healthy cells like osteoblasts. 
7.7.4  Doxorubicin loading to Fe2O3 nanoparticles 
After the surface of the Fe2O3 nanoparticles coated with the biopolymers 
Doxorubicin hydrochloride (DOX; (8s-cis)-10-[(3-amino-2,3,6-trideoxy-alpha-l-
lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-
1-methoxynaphthacene-5,12-dione hydrochloride) purchased from Edqm 
(D2975000) was loaded to synthesized particles with various drug concentrations 
(150, 300, 400, 500, 600 g/ml) in potassium phosphate buffer (PBS) purchased 
from Sigma–Aldrich Co. Chemical structure representation of DOX is given in 
Figure 7.18. 
 
Figure 7.18:  Chemical structure representation of DOX [80]. 
The mixture of Fe2O3 nanoparticles coated with the biopolymers (2.5 mg/ml), 
Doxorubicin and potassium phosphate buffer was rotated (MARKA Rotator) at 90 
rpm with 5 s vibration intervals for 24 h in the light protected tubes at room 
temperature. Then, Doxorubicin loaded Fe2O3 nanoparticles coated with the 
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biopolymers were separated by magnetic decantation. The loading efficiency was 
quantified by measuring the absorbance values of unloaded drug in the supernatant 
with a UV-spectrophotometer at 481 nm [81]. 
Drug loading efficiency is obtained with uv/vis Spektrophotometer by using the 
formula below.    
    (7. 3) 
The Figure 7.19 shows drug loading efficiencies of 1g/L HEC+2% Fe2O3, for 1g/L 
NC+2% Fe2O3 particles. 
 
Figure 7.19: Drug loading % of 1g/L HEC+2% Fe2O3, for 1g/L NC+2% Fe2O3 
particles. 
7.7.4.1 In vitro evaluations for DOX loaded nanoparticles  
Particles were loaded with DOX, which is an antitumor drug with methods 
mentioned at section 7.7.4. Loading efficiencies were calculated and drug loading 
capacities were obtained. Later DOX loaded particles were tested with MCF7 cell 
line to examine drug loading effects of nanoparticles and and their effect on the 
viability of the cells. Cell viability % of MCF7 cells were determined the results are 
given in Figure 7.20.  
The results show that DOX was successfully loaded to particles and had a drastic 
effect on the cell viabilities. Toxicity of the DOX loaded particles are very high at 
400, 250, 200 g/ml concentrations. DOX loaded 1g/L HEC+2% Fe2O3 particles 
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showed more toxicity than DOX loaded 1g/L NC+2% Fe2O3 particles, These results 
were as expected because 1g/L HEC+2% Fe2O3 particles were able to adsorb mode 
DOX than NC polymer coated particles (as seen in Figure 7.19).  
 
Figure 7.20: Relative cell viability (%) of MCF-7 treated with DOX loaded 1g/L 
HEC+2% Fe2O3 and 1g/L NC+2% Fe2O3 particles. 
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8. CONCLUSIONS  
In this study the goal was to synthesize multifunctional magnetic nanopatricles with 
optimum properties suitable for using in targeted drug delivery systems. When 
designing and synthesizing multifunctional nanoparticles all advantages and 
disadvantages were considered. Choosen polymers for this study were HEC an NC 
which are cellulosic and biocompatible. To reach a positive result characterization of 
particles and optium polymer concentration determination is important. 
Characterization techniques are required to determine magnetic nanoparticle 
properties such as size, crystal structure, material’s thermal stability, absorbtion 
spectrum and magnetic behavior.The stable and fully covered surfaces of the MNPs 
were characterized by the conventional methods such as scanning electron 
microscopy (SEM) for the determination of the size and morphology, X-ray 
diffraction (XRD) to determine crystal structure, Fourier transform infrared 
spectroscopy (FTIR) to analyze the chemical bonds and functional groups, 
thermogravimetric analysis (TGA) to determine material’s thermal properties and 
vibrating sample magnetometers (VSM) to measure the magnetic properties.After the 
characterization of MNP, the in vitro evaluations will give insight about biological 
compatibility and toxicity of synthesized particles. 
Rheological and electrokinetic measurements provided significant information for 
determining the optimum biopolymer concentrations. The rheological and the 
electrokinetical measurements did not show much change in the flow or the 
aggregation behavior for the biopolymer HEC. On the other hand, Zeta potential 
measurements showed that HEC covered the whole surfaces of the iron oxide 
particles after the 0.05g/L HEC concentration. Because HEC did not change any 
structural properties of Fe2O3 nanoparticles it can be said that the attachment of HEC 
to the Fe2O3 particle surfaces is completely caused by electrosteric effects. Positively 
charged HEC were attracted to the negatively charged surface of Fe2O3 and HEC 
changed the charge distribution on the Fe2O3 surface, which reduced the entropy of 
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the particle. Rheological and the electrokinetical behaviours of NC biopolymer were 
very similar to HEC, only NC was not able to cover Fe2O3 surface as much as HEC.  
Magnetorheometers are used for studying the changes in flow properties that occur in 
fluids which are exposed to controlled magnetic fields. When an external magnetic 
field is applied, there is a drastic change on the flow properties of the magnetic 
suspensions.  Because only possibility to target MNPs to desited sites is to apply 
external magnetic field, assessment of magnetorheological flow properties are crutial 
for designing MNPs suitable for drug delivery systems. Magnetorheological results 
of synthesized MNPs showed similar results for both HEC and NC polymers. Resuts 
indicated that as polymer concentration increased viscosity of biopolymer coated 
Fe2O3 particles (under applied magnetic field) decreased. Espessially for 1g/L of 
polymer concentrations the desired magnerorheological properties were observed for 
both polymers HEC and NK. This property gained by adsorbing polymers to Fe2O3 
surface can aid nanoparticles to have fluid behaviours instead of solid phase 
behaviours under applied magnetic field. This is an advantage for MNP drug delivery 
systems because when they are used in systematic applications MNPs should have 
fluid flow behavior under magnetic fields to reach the target site. 
FTIR measurements showed that characteristic Fe-O streching vibration peak of  
Fe2O3 was at 576 cm
-1
. The results indicated that addition of the polymers HEC and 
NC did not change the spectrum of Fe2O3 but characteristic Fe-O vibration peaks 
were slightly shifted. The reason for this shift was overlapping of polymer and Fe2O3 
peaks. No binding peaks were observed as expected.  
The crystal structure of Fe2O3 and Fe2O3 in the presence of HEC was measured by 
X-Ray diffraction analysis. According to the results, no changes were determined as 
HEC concentration changed. Therefore, crystal structure was not affected by 
polymer interactions.  
Scanning electron microscopic (SEM) images of the samples were used for 
characterization of the dispersions with the polymer effect. Direct evidence of 
surface modification of the dispersion can be seen in SEM examination of the cross-
section of particles (at section 7.5.6). SEM images of all Fe2O3 nanoparticles and 
HEC biopolymer coated Fe2O3 nanoparticles were obtained for particle size 
determination and imaging. HEC polymer appeared on the ironoxide particles as 
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dotted texture. The increasing concentration of HEC polymer increased the number 
of coated Fe2O3 nanoparticles as seen on the SEM pictures. 
For the further studies, it is decided to use 1g/L HEC and 1g/L NC concentration for 
synthesizing multifunctional magnetic Fe2O3 nanoparticles because of the reasons 
above. After optimum concentrations of biopolymers were choosen, Thermo-
gravimetric analyses in vitro toxicity evaluations were executed and magnetic 
properties of synthesized Fe2O3 nanoparticles were examined. 
Becouse targeting of multifunctional magnetic Fe2O3 nanoparticles will be with 
magnetic field applications and manipulations it is important that particles do not 
lose their magnetic properties. Whether biopolymer coating of Fe2O3 nanoparticles 
affected their magnetic properties were examined with vibrating sample 
magnetometer. The results indicated that polymer adsorption to Fe2O3 particles 
reduced the magnetization values slightly but did not change the characteristic 
response of Fe2O3 particles to the magnetic field.  
The thermal analyses of the samples were determined using thermo gravimetric (TG) 
and differential thermal analysis (DTA). The results showed uncoated Fe2O3 particles 
gained significant amount of weight at temperatures in the range of 30 to 300 °C. 
This indicates that these particles were oxidized when uncoated. Coated and 
uncoated Fe2O3 particles showed different weigth lost events. HEC and NC coated 
particles were not oxidized because of coatings prevented Fe2O3 particles to intreract 
with the environment, so, they are not oxidized and they lost weight due to the 
polymers weigth lost. 
We have mentioned that evaluating the toxicological effects of MNPs both in vitro is 
crucial for the development of multifunctional magnetic Fe2O3 nanoparticles for 
using in medical applications. In order to assess whether synthesized Fe2O3 
nanoparticles could have anticancer drug potential and targeted drug delivery 
properties in vitro evaluations were performed. To examine the toxicity of 
synthesized Fe2O3 nanoparticles, cytotoxicity assays were performed for all 
nanoparticle samples using MTS assays. First, cytotoxity assays were performed on 
healthy cells to examine the toxic effects of Fe2O3 particles and their biopolymer-
coated samples. Cytotoxicity assays showed that HEC coated Fe2O3 nanoparticle 
dilutions has considerably less toxicity to osteoblast cells than uncoated Fe2O3 
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dilutions. Experimental values indicate that HEC coated Fe2O3 nanoparticles has less 
cell toxicity and these nanoparticles may have potential to be used as a drug targeting 
and delivering model with less toxicity to healthy cells like osteoblast cell lines. 
After testing toxicity of biopolymer-coated nanoparticles on healthy cells, the 
particles were loaded with DOX, which is an antitumor drug. Loading efficiencies 
were calculated and drug loading capacities were obtained. As the results showed 
1g/L HEC + 2% Fe2O3 and 1g/L NC + 2%, Fe2O3 particles were able to adsorb 
DOX at 87.36% and 70.92 % capacity (respectively). 
Later DOX loaded particles were tested with MCF7 cell line to examine drug loading 
effects on nanoparticles and viability of cells.The results showed that DOX was 
successfully loaded to particles and toxicity of the DOX loaded particles were very 
high at 400, 250, 200 g/ml concentrations. DOX loaded 1g/L HEC+2% Fe2O3 
particles showed more toxicity than DOX loaded 1g/L NC+2% Fe2O3 particles, 
These results were as expected because 1g/L HEC+2% Fe2O3 particles were able to 
adsorb mode DOX than NC polymer coated particles. 
In conclusion, this study showed that 1g/L HEC+2% Fe2O3 and 1g/L NC+2% Fe2O3 
particles have the potential to be used in drug delivery systems for cancer therapies 
and also in hyperthermia treatments. For further studies, in vivo effects of these 
particles are planned to be examined to determine their systematic interactions within 
a living organism.  
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